Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival from Colon Cancer: A United States Population-Based Study

Gastroenterology

Volumn 150, Issue 5, 2016, Pages 1135-1146

  Lai, Yinzhi ^a   Wang, Chun ^a   Civan, Jesse M ^b   Palazzo, Juan P ^b   Ye, Zhong ^a   Hyslop, Terry ^c   Lin, Jianqing ^a   Myers, Ronald E ^a   Li, Bingshan ^d   Jiang, Binghua ^b   Sama, Ashwin ^a   Xing, Jinliang ^e   Yang, Hushan ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal Cancer; CRC; Outcome; Race

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLACK PERSON; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDIAN SURVIVAL TIME; POVERTY; PRIORITY JOURNAL; RACE DIFFERENCE; RURAL POPULATION; SOCIAL STATUS; SURVIVAL TIME; UNITED STATES; URBAN POPULATION; URBAN RURAL DIFFERENCE; AFRICAN AMERICAN; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; COLONIC NEOPLASMS; COMORBIDITY; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DISPARITY; HEALTH DISPARITY; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOCIOECONOMICS; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; TUMOR VOLUME;

AFRICAN AMERICANS; AGED; COLONIC NEOPLASMS; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; UNITED STATES;

EID: 84962184559     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.01.030     Document Type: Article

References (60)

1. K. Irby, W.F. Anderson, D.E. Henson, and et al. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002) Cancer Epidemiol Biomarkers Prev 15 2006 792 797
2. S.S. Grubbs, B.N. Polite, J. Carney, and et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village J Clin Oncol 31 2013 1928 1930
3. A.S. Robbins, R.L. Siegel, and A. Jemal Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008 J Clin Oncol 30 2012 401 405
4. D.R. Simpson, M.E. Martínez, S. Gupta, and et al. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer J Natl Cancer Inst 105 2013 1814 1820
5. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review 1975-2012. National Cancer Institute. Bethesda, MD. Available at http://seer.cancer.gov/csr/1975-2012/. Accessed April 2015.
6. D. Alexander, C. Chatla, E. Funkhouser, and et al. Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma Cancer 101 2004 66 76
7. A.O. Laiyemo, C. Doubeni, P.F. Pinsky, and et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities J Natl Cancer Inst 102 2010 538 546
8. X.L. Du, S. Fang, S.W. Vernon, and et al. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer Cancer 110 2007 660 669
9. X.L. Du, T.E. Meyer, and L. Franzini Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer Cancer 109 2007 2161 2170
10. G.M. Rodgers 3rd, P.S. Becker, C.L. Bennett, and et al. Cancer- and chemotherapy-induced anemia J Natl Compr Canc Netw 6 2008 536 564
11. E. Ward, A. Jemal, V. Cokkinides, and et al. Cancer disparities by race/ethnicity and socioeconomic status CA Cancer J Clin 54 2004 78 93
12. V.E. Lemmens, A.H. van Halteren, M.L. Janssen-Heijnen, and et al. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity Ann Oncol 16 2005 767 772
13. C.A. Doubeni, T.S. Field, D.S. Buist, and et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population Cancer 109 2007 612 620
14. D.D. Alexander, J. Waterbor, T. Hughes, and et al. African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: An epidemiologic review Cancer Biomark 3 2007 301 313
15. V.L. Shavers, and M.L. Brown Racial and ethnic disparities in the receipt of cancer treatment J Natl Cancer Inst 94 2002 334 357
16. L.J. Wudel Jr., W.C. Chapman, Y. Shyr, and et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival Arch Surg 137 2002 550 554
17. B.N. Polite, J.J. Dignam, and O.I. Olopade Colorectal cancer model of health disparities: understanding mortality differences in minority populations J Clin Oncol 24 2006 2179 2187
18. J.A. Laryea, E. Siegel, and S. Klimberg Racial disparity in colorectal cancer: the role of equal treatment Dis Colon Rectum 57 2014 295 302
19. C.D. Mack, W. Carpenter, A.M. Meyer, and et al. Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults Cancer 118 2012 2925 2934
20. J.A. Dominitz, G.P. Samsa, P. Landsman, and et al. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system Cancer 82 1998 2312 2320
21. J.H. Silber, P.R. Rosenbaum, A.S. Clark, and et al. Characteristics associated with differences in survival among black and white women with breast cancer JAMA 310 2013 389 397
22. S.R. Daniel, K. Armstrong, J.H. Silber, and et al. An algorithm for optimal tapered matching, with application to disparities in survival J Comput Graph Stat 17 2008 914 924
23. D. Yang, D.S. Small, J.H. Silber, and et al. Optimal matching with minimal deviation from fine balance in a study of obesity and surgical outcomes Biometrics 68 2012 628 636
24. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
25. P.C. O'Brien, and T.R. Fleming A paired Prentice-Wilcoxon test for censored paired data Biometrics 43 1987 169 180
26. L.J. Wei, Z. Ying, and D.Y. Lin Linear regression analysis of censored survival data based on rank tests Biometrika 77 1990 845 851
27. H. Le, A. Ziogas, S.M. Lipkin, and et al. Effects of socioeconomic status and treatment disparities in colorectal cancer survival Cancer Epidemiol Biomarkers Prev 17 2008 1950 1962
28. N.U. Ahmed, V. Pelletier, K. Winter, and et al. Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening Am J Public Health 103 2013 e91 e99
29. Eloxatin: new or modified indication 2004 US Food and Drug Administration Washington, DC
30. US Food and Drug Administration. FDA approves first angiogenesis inhibitor to treat colorectal cancer. Available at: http://www.fda.gov/newsevents/newsroom/pressannouncements/2004/ucm108252.htm. Accessed February 26, 2004.
31. B. Gustavsson, G. Carlsson, D. Machover, and et al. A review of the evolution of systemic chemotherapy in the management of colorectal cancer Clin Colorectal Cancer 14 2015 1 10
32. F. Petrelli, A. Coinu, M. Ghilardi, and et al. Efficacy of oxaliplatin-based chemotherapy + bevacizumab as first-line treatment for advanced colorectal cancer: a systematic review and pooled analysis of published trials Am J Clin Oncol 38 2015 227 233
33. E. Van Cutsem, F. Rivera, S. Berry, and et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study Ann Oncol 20 2009 1842 1847
34. H.S. Hochster, L.L. Hart, R.K. Ramanathan, and et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study J Clin Oncol 26 2008 3523 3529
35. B.J. Giantonio, P.J. Catalano, N.J. Meropol, and et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 J Clin Oncol 25 2007 1539 1544
36. F.F. Kabbinavar, J. Hambleton, R.D. Mass, and et al. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer J Clin Oncol 23 2005 3706 3712
37. H. Hurwitz, L. Fehrenbacher, W. Novotny, and et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
38. N. Kemeny, C.A. Garay, J. Gurtler, and et al. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer J Clin Oncol 22 2004 4753 4761
39. R.M. Mayberry, R.J. Coates, H.A. Hill, and et al. Determinants of black/white differences in colon cancer survival J Natl Cancer Inst 87 1995 1686 1693
40. C.P. Theuer, J.L. Wagner, T.H. Taylor, and et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States Gastroenterology 120 2001 848 856
41. D.K. Rex, D.A. Johnson, J.C. Anderson, and et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008 Am J Gastroenterol 104 2009 739 750
42. D.K. Rex, A.M. Khan, P. Shah, and et al. Screening colonoscopy in asymptomatic average-risk African Americans Gastrointest Endosc 51 2000 524 527
43. S. Agrawal, A. Bhupinderjit, M.S. Bhutani, and et al. Colorectal cancer in African Americans Am J Gastroenterol 100 2005 515 523
44. L. Hoffman-Goetz, N.L. Breen, and H. Meissner The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States Ethn Dis 8 1998 43 51
45. S. Marcella, and J.E. Miller Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status J Clin Epidemiol 54 2001 359 366
46. A.M. Morris, K.G. Billingsley, N.N. Baxter, and et al. Racial disparities in rectal cancer treatment: a population-based analysis Arch Surg 139 2004 151 155
47. J. Berry, K. Bumpers, V. Ogunlade, and et al. Examining racial disparities in colorectal cancer care J Psychosoc Oncol 27 2009 59 83
48. Y. Hao, H. Landrine, A. Jemal, and et al. Race, neighbourhood characteristics and disparities in chemotherapy for colorectal cancer J Epidemiol Community Health 65 2011 211 217
49. N.A. Obeidat, F.G. Pradel, I.H. Zuckerman, and et al. Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer Am J Manag Care 16 2010 515 522
50. A. White, C.C. Liu, R. Xia, and et al. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002 Cancer 113 2008 3400 3409
51. C.P. Gross, B.D. Smith, E. Wolf, and et al. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer 112 2008 900 908
52. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
53. P.R. Rosenbaum, and D.B. Rubin Constructing a control group using multivariate matched sampling methods that incorporate the propensity score Am Stat 39 1985 33 38
54. P.R. Rosenbaum, R.N. Ross, and J.H. Silber Minimum distance matched sampling with fine balance in an observational study of treatment for ovarian cancer J Am Stat Assoc 102 2007 75 83
55. H. Brenner, M. Kloor, and C.P. Pox Colorectal cancer Lancet 383 2014 1490 1502
56. S. Shiovitz, A. Bansal, A.N. Burnett-Hartman, and et al. Cancer-directed therapy and hospice care for metastatic cancer in American Indians and Alaska natives Cancer Epidemiol Biomarkers Prev 24 2015 1138 1143
57. L.J. Joseph, M. Goodman, K. Higgins, and et al. Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis Oral Oncol 51 2015 586 592
58. H. Wang, T. Burnett, S. Kono, and et al. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A Nat Commun 5 2014 4613
59. M. Lian, M. Schootman, C.A. Doubeni, and et al. Geographic variation in colorectal cancer survival and the role of small-area socioeconomic deprivation: a multilevel survival analysis of the NIH-AARP Diet and Health Study Cohort Am J Epidemiol 174 2011 828 838
60. L.M. Baldwin, S.A. Dobie, K. Billingsley, and et al. Explaining black-white differences in receipt of recommended colon cancer treatment J Natl Cancer Inst 97 2005 1211 1220